381 related articles for article (PubMed ID: 28591265)
1. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
Membrive NA; Kazuma FJ; Silveira TGV; Teixeira JJV; Reinhold-Castro KR; Teodoro U
Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e37. PubMed ID: 28591265
[TBL] [Abstract][Full Text] [Related]
2. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
3. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
Parasite; 2017; 24():34. PubMed ID: 28959938
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
Romero GA; Guerra MV; Paes MG; Macêdo VO
Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
[TBL] [Abstract][Full Text] [Related]
5. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
6. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil.
Fernandes AC; Pedroso RB; de Mello TF; Donatti L; Venazzi EA; Demarchi IG; Aristides SM; Lonardoni MV; Silveira TG
Exp Parasitol; 2016 Aug; 167():83-93. PubMed ID: 27181585
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
9. Personal experience with diagnostic and therapeutic aspects of human Leishmania (Viannia) braziliensis in Três Braços.
Marsden PD
Mem Inst Oswaldo Cruz; 1994; 89(3):485-7. PubMed ID: 7476237
[TBL] [Abstract][Full Text] [Related]
10. Zosteriform cutaneous leishmaniasis due to Leishmania ( Viannia ) panamensis and Leishmania ( Viannia ) braziliensis: report of three cases.
Morales CA; Palacio J; Rodríguez G; Camargo YC
Biomedica; 2014; 34(3):340-4. PubMed ID: 25504121
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma.
Quintella LP; Cuzzi T; de Fátima Madeira M; Valete-Rosalino CM; de Matos Salgueiro M; de Camargo Ferreira e Vasconcellos E; Mouta-Confort E; Lambert Passos SR; de Oliveira Schubach A
Am J Dermatopathol; 2011 Aug; 33(6):642-4. PubMed ID: 21778837
[No Abstract] [Full Text] [Related]
12. Intermediate/borderline disseminated cutaneous leishmaniasis.
Paniz Mondolfi AE; Duffey GB; Horton LE; Tirado M; Reyes Jaimes O; Perez-Alvarez A; Zerpa O
Int J Dermatol; 2013 Apr; 52(4):446-55. PubMed ID: 23231577
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
Hernández DE; Oliver M; Martínez C; Planas G
Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768
[No Abstract] [Full Text] [Related]
14. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Krolewiecki AJ; Romero HD; Cajal SP; Abraham D; Mimori T; Matsumoto T; Juarez M; Taranto NJ
Am J Trop Med Hyg; 2007 Oct; 77(4):640-6. PubMed ID: 17978064
[TBL] [Abstract][Full Text] [Related]
15. Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
Romero GA; Molinet FJ; Noronha EF
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):266-8. PubMed ID: 23315614
[TBL] [Abstract][Full Text] [Related]
16. [American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis in military training area of Zona da Mata in Pernambuco].
Andrade MS; Brito ME; Silva ST; Lima BS; Almeida EL; Albuquerque EL; Marinho Júnior JF; Ishikawa E; Cupolillo E; Brandão-Filho SP
Rev Soc Bras Med Trop; 2005; 38(3):229-33. PubMed ID: 15895173
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
[No Abstract] [Full Text] [Related]
18. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
Netto EM; Marsden PD; Llanos-Cuentas EA; Costa JM; Cuba CC; Barreto AC; Badaró R; Johnson WD; Jones TC
Trans R Soc Trop Med Hyg; 1990; 84(3):367-70. PubMed ID: 2260171
[TBL] [Abstract][Full Text] [Related]
19. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.
Sinagra A; Luna C; Abraham D; Iannella Mdel C; Riarte A; Krolewiecki AJ
Rev Soc Bras Med Trop; 2007; 40(6):627-30. PubMed ID: 18200413
[TBL] [Abstract][Full Text] [Related]
20. [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety].
Saldanha AC; Romero GA; Merchan-Hamann E; Magalhães AV; Macedo Vde O
Rev Soc Bras Med Trop; 1999; 32(4):383-7. PubMed ID: 10495667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
